A significant increase in the cost of over-the-counter (OTC) similar drugs has been approved by a regulatory committee in Japan. The decision is likely to increase the financial burden on consumers depending on these health products. It remains unclear when the changes will come into effect, and what exactly motivated the approval of this measure.

Japan's universal healthcare system extends to cover prescription drugs, but not OTC medicine unless prescribed by a doctor. Many elderly people and chronic disease sufferers depend heavily on these medications. This cost increase is likely to stir controversy and stress among these demographics, and raise debates about healthcare costs in Japan.

In the US or EU, similar issues regarding medication costs, especially for uninsured citizens, have been contentious for years. The rising costs of both prescription and OTC drugs have sparked debate over health care reform and the role of regulatory bodies in controlling drug prices.